| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
6.64(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.08 - $16.46 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.5 |
| Insider 6 Months : 11.5 |
| Insider 3/6 Months : 23 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
38,100 |
38,100 |
38,100 |
157,300 |
| Total Buy Value |
$617,802 |
$617,802 |
$617,802 |
$2,415,734 |
| Total People Bought |
3 |
3 |
3 |
7 |
| Total Buy Transactions |
3 |
3 |
3 |
12 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simmons Jeffrey N |
President, CEO and Director |
• • – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
229,655 |
782,418 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,540 |
14,607 |
|
- |
|
| Kochevar Deborah Turner |
Director |
– • – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,307 |
22,208 |
|
- |
|
| Herendeen Paul |
Director |
– • – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,307 |
7,307 |
|
- |
|
| Anand Kapila K |
Director |
– • – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,307 |
26,467 |
|
- |
|
| Hoover R David |
See Remarks |
– • – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,307 |
39,267 |
|
- |
|
| Hoover R David |
See Remarks |
– • – |
2021-11-30 |
4 |
B |
$29.38 |
$293,794 |
I/I |
10,000 |
105,000 |
2.1 |
-10% |
|
| Harrington Michael J |
Director |
– • – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,307 |
35,471 |
|
- |
|
| Harrington Michael J |
Director |
– • – |
2021-11-30 |
4 |
B |
$29.25 |
$73,123 |
D/D |
2,500 |
28,164 |
2.39 |
-10% |
|
| Bilbrey John P |
Director |
– • – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,307 |
21,208 |
|
- |
|
| Kurzius Lawrence Erik |
Director |
– • – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,307 |
34,267 |
|
- |
|
| Hoover R David |
See Remarks |
– • – |
2021-11-15 |
4 |
B |
$31.79 |
$158,935 |
I/I |
5,000 |
95,000 |
2.1 |
-14% |
|
| De Brabander Ellen |
See Remarks |
• – – |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,635 |
45,635 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2021-10-20 |
4 |
D |
$33.66 |
$69,508 |
D/D |
(2,065) |
75,378 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2021-10-20 |
4 |
D |
$33.66 |
$102,394 |
D/D |
(3,042) |
70,242 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2021-10-20 |
4 |
D |
$33.66 |
$67,152 |
D/D |
(1,995) |
54,377 |
|
- |
|
| Schacht Aaron L |
Executive Vice President |
• – – |
2021-10-20 |
4 |
D |
$33.66 |
$69,508 |
D/D |
(2,065) |
78,747 |
|
- |
|
| Simmons Jeffrey N |
President, CEO and Director |
• • – |
2021-10-20 |
4 |
D |
$33.66 |
$532,299 |
D/D |
(15,814) |
552,763 |
|
- |
|
| Hoover R David |
See Remarks |
– • – |
2021-08-16 |
4 |
B |
$31.45 |
$251,592 |
I/I |
8,000 |
90,000 |
2.1 |
-8% |
|
| Hoover R David |
See Remarks |
– • – |
2021-08-13 |
4 |
B |
$30.75 |
$61,490 |
I/I |
2,000 |
82,000 |
2.1 |
-7% |
|
| Harrington Michael J |
Director |
– • – |
2021-08-11 |
4 |
B |
$28.99 |
$86,955 |
D/D |
3,000 |
25,684 |
2.39 |
-1% |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2021-08-11 |
4 |
B |
$29.70 |
$500,445 |
D/D |
16,850 |
568,577 |
2.81 |
-1% |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2021-06-03 |
4 |
D |
$35.00 |
$2,450 |
D/D |
(70) |
11,067 |
|
- |
|
| Hoover R David |
See Remarks |
– • – |
2021-05-11 |
4 |
B |
$32.44 |
$811,000 |
I/I |
25,000 |
70,000 |
2.1 |
-1% |
|
| Garcia Art A |
Director |
– • – |
2021-05-11 |
4 |
B |
$32.88 |
$50,142 |
D/D |
1,525 |
16,465 |
2.39 |
-1% |
|
390 Records found
|
|
Page 8 of 16 |
|
|
0.26 (1.96%) 
